FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Microspheres Radionuclide
PMA: P200029
·
Supplement: S005
·
Decision Jul 26, 2023
Classifications
1
FEI Numbers
8
Registration Numbers
8
Basic Information
- Device Name
- Microspheres Radionuclide
- Trade Name
- TheraSphere
- PMA Number
- P200029
- Supplement Number
- S005
- Device Class
- FDA Class 3
- Product Code
- NAW
- Generic Name
- Microspheres radionuclide
- Medical Specialty
- Unknown
- Advisory Committee
- Radiology
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- July 26, 2023
- Date Received
- June 26, 2023
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Supplier changes within the production of Loctite 4307 which is used in the manufacturing of the TheraSphere Administration Set manufactured by CEA.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NAW | Microspheres Radionuclide | FDA class 3 | Unknown |